Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0779 per EA under NDC 69097007112. Its NADAC has been published 130 times since Jan 3, 2024.
Strength
150 mg/1
Manufacturer
Cipla USA Inc.NDC
69097007112
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207479On Market Since
10/25/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 130 times since Jan 3, 2024, and over the history we have for it it has declined 31.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0779 per EA |
|---|---|
| All-time high | $0.1215 (Apr 10, 2024) |
| All-time low | $0.0745 (Nov 20, 2024) |
| 52-week high | $0.1042 |
| 52-week low | $0.0770 |
| Median price | $0.1002 |
| Average price | $0.0984 |
| Largest weekly change | -30.3% (Nov 20, 2024) |
| Weeks tracked | 130 |
| Tracking since | Jan 3, 2024 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Cipla USA Inc., is $0.0779 per EA (NDC 69097007112), effective Jun 24, 2026.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 31.5%. It has been tracked across 130 weekly CMS publications since Jan 3, 2024.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Jan 3, 2024, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.1215 (Apr 10, 2024), with a median of $0.1002 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as BUPROPION HCL XL 150 MG TABLET, but none are currently priced below it.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 69097007112) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification